Like Bio-Hermes-001, the Bio-Hermes-002 study is paving the way for improving participation by trial participants who are traditionally underrepresented in Alzheimer’s clinical research, with an ...
The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Michel Robidoux, ...
Barclays analyst Emily Field maintained a Buy rating on Sandoz Group Ltd (SDZXF – Research Report) today and set a price target of CHF50.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback